Lars Peter Holst Andersen: Clinical Trials

1 trial sponsored by Lars Peter Holst Andersen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow Lars Peter Holst Andersen: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Analgesic Effects of Melatonin
Melatonin 10 mg, Melatonin 100 mg, Placebo - Analgesia, Antihyperalgesia
Phase 2 / Phase 3CompletedLars Peter Holst Andersen362013-08-012014-10-22

Conditions studied

Agnosia (1)

Interventions

Melatonin (1)

Countries

Denmark (1)

Top investigators

Lars P.H. Andersen, MD (1)

Results publications

PMID 26893170